Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

New JA-14.50 Rotors from Beckman Coulter Life Sciences

Published: Friday, March 14, 2014
Last Updated: Friday, March 14, 2014
Bookmark and Share
High performance unit supports full range of common tubes.

Designed for applications that use common, disposable conical tubes, JA-14.50 rotors from Beckman Coulter Life Sciences extend the applications and flexibility of the company’s Avanti centrifuge series, and can be used in Avanti J-26S, J-30I and J-E centrifuges.

While greater capacity results in higher throughput, the rotors maintain the precision performance offered by products in the Avanti line and are the only high-performance rotors capable of spinning 50, 15, 5 and 1.5mL conical tubes, and 50, 15 and 10 mL round bottom tubes and bottles at their maximum speeds.

Delivering a top speed of 14,000 rpm and rcf of 35,000 x g, JA-14.50 rotors hold up to 16 x 50 mL conical tubes and maximize the number of 50mL conical tubes that can be processed in a single run.

The fixed-angle rotor is intended for general pelleting of cells, bacteria and food products; separating proteins, viruses and sub cellular fractions; running concentrators and columns; and for phase separation and binding studies.

Avanti centrifuges are available with a selection of BioCertified fixed-angle and swinging-bucket rotors, ranging in capacity from 360 mL to 6 L and all independently certified to contain liquids and aerosols. A BioCertified dual-locking lid configuration, for workflows that include biohazardous samples, maintains biocontainment when removing the rotor from the centrifuge and transporting it to a containment hood. Rotors are also available in a standard single-locking lid configuration.

Avanti rotors, including the new JA-14.50 rotor, have a unique ID that is tracked using magnetic sensors; the centrifugation system uses Dynamic Rotor Inertia Check and the ID for Automatic Rotor Identification and to ensure that no individual rotor exceeds the maximum speed permitted.

“We’re proud to introduce the JA-14.50 rotor - it improves workflows, saving scientists’ time, and is useful across a diverse array of applications where a variety of conical tube sizes are commonly used,” said Randall Lockner, marketing manager at Beckman Coulter Life Sciences. “Users can rely upon the quality, performance and efficiency for which Beckman Coulter centrifugation products are known.”

In addition to compatibility with current models, JA-14.50 rotors can be used in installed Avanti J-20 and J-25 centrifuges.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Beckman Coulter Diagnostics Obtains CE Marks for DxN VERIS HCV Assay
Growing menu of assays allow for rapid turnaround of results with a more efficient workflow.
Thursday, June 11, 2015
FDA Clears Beckman's AQUIOS CL Flow Cytometer For Clinical Labs
The company's new, automated AQUIOS CL Flow Cytometer has received clearance from the U.S. Food and Drug Administration (FDA) for routine applications in the clinical laboratory.
Wednesday, May 06, 2015
Beckman Coulter Diagnostics and Seegene Supply Agreement
Supply agreement announced for multiplex reagents for VERIS molecular diagnostics system.
Monday, November 17, 2014
Beckman Coulter Obtains CE Mark for VERIS MDx System
Beckman Coulter Diagnostics has obtained CE Mark for the VERIS MDx System* and VERIS human Cytomegalovirus (CMV) assay*.
Monday, May 12, 2014
Beckman To Acquire Cytometer Developer Xitogen
Acquisition will broaden product offering, providing an Asian operations centre.
Wednesday, April 23, 2014
New Beckman Coulter Assay Receives FDA Clearance and CE Mark
Assay is first to standardize to World Health Organization’s 5th International Standard for chorionic gonadotropin.
Friday, January 17, 2014
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
'Fountain of Youth' Protein Points to Possible Human Health Benefit
Patients with higher blood levels of growth factor have lower risk of cardiovascular problems.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Imaging Software Could Speed Breast Cancer Diagnosis
Technology could improve access to diagnostic services in developing countries.
Data Mining DNA For Polycystic Ovary Syndrome Genes
A new Northwestern Medicine genome-wide association study of PCOS – the first of its kind to focus on women of European ancestry – has provided important new insights into the underlying biology of the disorder.
Algorithm Interprets Breathing Difficulties to Aid in Medical Care
Researchers from North Carolina State University have developed an efficient algorithm that can interpret the wheezing of patients with breathing difficulties to give medical providers information about what’s happening in the lungs.
Researchers Develop qPCR Prognosis Test for NSCLC Patients
A nine-gene molecular prognostic index (MPI) for patients with early-stage non-small cell lung cancer (NSCLC) was able to provide accurate survival stratification and could potentially inform the use of adjuvant therapy in patients struggling with the disease.
Genetic Test Could Improve Blood Cancer Treatment
Testing for genetic risk factors could improve treatment for myeloma – a cancer of the blood and bone marrow – by helping doctors identify patients at risk of developing more aggressive disease.
PTR-MS Breath Test Shows Potential for Detecting Liver Disease
Researchers at the University of Birmingham have published results that suggest a non-invasive breath test for liver disease using an IONICON PTR-MS.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!